Clinical Trials in North Carolina

Showing 8701-8720 of 20,428 trials

The Effects of Animal Assisted Therapy in Outpatient Psychiatry Clinics

NCT05326074

This study will examine whether a session of animal-assisted therapy reduces anxiety levels and improves long-term clinical outcomes of outpatient psychiatric patients in regard to their Generalized Anxiety Disorder (GAD-7), Patient Health Questionnaire (PHQ-9 - Depression assessment), Three Item Loneliness scale (TIL), and Mean Arterial Blood Pressure.

AnxietyDepressionPsychiatric or Mood Diseases or Conditions

Wake Forest University Health Sciences7 participantsStarted Jul 2022

Winston-Salem, North Carolina, United States

COMPLETEDPhase 141 miles

Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery

NCT02583269

This phase I trial studies the side effects and the best dose of muscadine grape skin extract (MGE) in treating patients with malignancy (tumor or cancer) that has spread to other parts of the body or cannot be removed by surgery. MGE is a nutritional supplement containing an extract of the skin of muscadine grape that has shown anti-cancer activity in laboratory studies and may be able to fight or kill malignant cells.

Advanced Malignant NeoplasmMetastatic Malignant NeoplasmUnresectable Malignant Neoplasm

Wake Forest University Health Sciences24 participantsStarted Mar 2016

Winston-Salem, North Carolina, United States

COMPLETEDNA41 miles

mHealth Physical Activity Intervention for Survivors of Adolescent and Young Adult Cancers

NCT03386383

The purpose of this study is to examine the feasibility, acceptability, and gather preliminary data on outcomes of a 3-month mHealth intervention to promote physical activity among adolescent and young adult (AYA) cancer survivors compared to a delayed intervention control group.

CancerPhysical Activity

UNC Lineberger Comprehensive Cancer Center64 participantsStarted Feb 2018

Chapel Hill, North Carolina, United States • Durham, North Carolina, United States • Winston-Salem, North Carolina, United States

The Effects of Animal Assisted Therapy in Outpatient Psychiatry Clinics

Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery

mHealth Physical Activity Intervention for Survivors of Adolescent and Young Adult Cancers

Find Trials by Condition in North Carolina

Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx

Open Trial of a Behavioral Activation Telepsychology Intervention for People Who Inject Drugs

Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder

Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Implementing Personal Health Records to Promote Evidence-Based Cancer Screening

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer